Stay updated on Daratumumab in NKTCL Clinical Trial
Sign up to get notified when there's something new on the Daratumumab in NKTCL Clinical Trial page.

Latest updates to the Daratumumab in NKTCL Clinical Trial page
- Check4 days agoChange DetectedDifference0.3%
- Check11 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.4%
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedThe page has undergone significant content removal, particularly regarding the details of a clinical study on daratumumab for natural killer/T-cell lymphomas, including its purpose, inclusion and exclusion criteria, and study director information. A new version number has been added, indicating an update.SummaryDifference14%
- Check33 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check76 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check91 days agoChange DetectedThe web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to Daratumumab in NKTCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab in NKTCL Clinical Trial page.